Published in J Nat Prod on July 01, 2001
ClusterMine360: a database of microbial PKS/NRPS biosynthesis. Nucleic Acids Res (2012) 1.31
Microtubule stabilizing agents as potential treatment for Alzheimer's disease and related neurodegenerative tauopathies. J Med Chem (2012) 1.17
Targeting microtubules by natural agents for cancer therapy. Mol Cancer Ther (2014) 1.08
Importance of microbial natural products and the need to revitalize their discovery. J Ind Microbiol Biotechnol (2013) 1.03
Characterization of the lnmKLM genes unveiling key intermediates for β-alkylation in leinamycin biosynthesis. Org Lett (2010) 0.88
Iterative polyketide biosynthesis by modular polyketide synthases in bacteria. Appl Microbiol Biotechnol (2015) 0.82
Cloning and expression of a cytochrome P450 hydroxylase gene from Amycolatopsis orientalis: hydroxylation of epothilone B for the production of epothilone F. J Ind Microbiol Biotechnol (2006) 0.80
Polyketide-nonribosomal peptide epothilone antitumor agents: the EpoA, B, C subunits. J Ind Microbiol Biotechnol (2003) 0.79
Enzymatic synthesis of epothilone A glycosides. AMB Express (2014) 0.78
Characterizing the Epothilone Binding Site on β-Tubulin by Photoaffinity Labeling: Identification of β-Tubulin Peptides TARGSQQY and TSRGSQQY as Targets of an Epothilone Photoprobe for Polymerized Tubulin. J Med Chem (2016) 0.76
Highly Efficient CYP167A1 (EpoK) dependent Epothilone B Formation and Production of 7-Ketone Epothilone D as a New Epothilone Derivative. Sci Rep (2015) 0.75
Partial In Vitro Reconstitution of an Orphan Polyketide Synthase Associated with Clinical Cases of Nocardiosis. ACS Chem Biol (2016) 0.75
Synthesis and Biological Evaluation of 7-Deoxy-Epothilone Analogues. Int J Mol Sci (2017) 0.75
Evidence for an iterative module in chain elongation on the azalomycin polyketide synthase. Beilstein J Org Chem (2016) 0.75
SmI2-promoted Reformatsky-type coupling reactions in exceptionally hindered contexts. Org Lett (2008) 0.75
In vivo evidence of structural brain asymmetry in musicians. Science (1995) 4.71
Topographical variation of the human primary cortices: implications for neuroimaging, brain mapping, and neurobiology. Cereb Cortex (1993) 2.68
Mutations in the SALL1 putative transcription factor gene cause Townes-Brocks syndrome. Nat Genet (1998) 2.39
Epothilons A and B: antifungal and cytotoxic compounds from Sorangium cellulosum (Myxobacteria). Production, physico-chemical and biological properties. J Antibiot (Tokyo) (1996) 2.22
Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis. Atherosclerosis (2007) 2.16
Anticoagulation monitoring and cerebral microemboli detection. Lancet (1994) 2.03
Taxonomy of the gliding bacteria. Annu Rev Microbiol (1981) 2.01
Asymmetry in the human motor cortex and handedness. Neuroimage (1996) 1.94
Increased corpus callosum size in musicians. Neuropsychologia (1995) 1.85
New onset hypertension after extracorporeal shock wave lithotripsy: age related incidence and prediction by intrarenal resistive index. J Urol (1997) 1.70
Dissociating neural correlates of cognitive components in mental calculation. Cereb Cortex (2001) 1.69
Endovascular treatment of symptomatic carotid stenosis using stent placement: long-term follow-up of patients with a balanced surgical risk/benefit ratio. Stroke (2001) 1.52
Cerebral microembolism in symptomatic and asymptomatic high-grade internal carotid artery stenosis. Neurology (1994) 1.52
Myxochelin A, a new iron-chelating compound from Angiococcus disciformis (Myxobacterales). Production, isolation, physico-chemical and biological properties. J Antibiot (Tokyo) (1989) 1.49
New lessons for combinatorial biosynthesis from myxobacteria. The myxothiazol biosynthetic gene cluster of Stigmatella aurantiaca DW4/3-1. J Biol Chem (1999) 1.49
Quantitative analysis of sulci in the human cerebral cortex: development, regional heterogeneity, gender difference, asymmetry, intersubject variability and cortical architecture. Hum Brain Mapp (1997) 1.48
The relationship between corpus callosum size and forebrain volume. Cereb Cortex (1997) 1.46
Cerebral microemboli in patients with antiphospholipid syndrome. Lupus (1997) 1.45
Phosphatidylserine IgG and beta-2-glycoprotein I IgA antibodies may be a risk factor for ischaemic stroke. Rheumatology (Oxford) (2005) 1.45
Motor cortex and hand motor skills: structural compliance in the human brain. Hum Brain Mapp (1997) 1.45
Mapping cortical gray matter in the young adult brain: effects of gender. Neuroimage (2005) 1.44
Interhemispheric asymmetry of the human motor cortex related to handedness and gender. Neuropsychologia (2000) 1.43
The chondramides: cytostatic agents from myxobacteria acting on the actin cytoskeleton. J Natl Cancer Inst (1998) 1.42
Structural asymmetries in the human forebrain and the forebrain of non-human primates and rats. Neurosci Biobehav Rev (1996) 1.41
Fine structure of fruiting bodies of Stigmatella aurantiaca (Myxobacterales). J Bacteriol (1969) 1.40
Sulcal variability of twins. Cereb Cortex (1999) 1.39
Transcranial Doppler ultrasonography in raised intracranial pressure and in intracranial circulatory arrest. J Neurosurg (1988) 1.35
The neural circuitry involved in the reading of German words and pseudowords: A PET study. J Cogn Neurosci (1999) 1.35
Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke. J Neurol Neurosurg Psychiatry (2005) 1.33
The sorangicins, novel and powerful inhibitors of eubacterial RNA polymerase isolated from myxobacteria. J Antibiot (Tokyo) (1987) 1.28
Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin. Blood (1997) 1.28
Structural changes in Stigmatella aurantiaca during myxospore induction. J Bacteriol (1969) 1.27
Serum GFAP is a diagnostic marker for glioblastoma multiforme. Brain (2007) 1.26
The myxopyronins, new inhibitors of bacterial RNA synthesis from Myxococcus fulvus (Myxobacterales). J Antibiot (Tokyo) (1983) 1.22
[The true nature of myxobacterial "rhapidosomes"]. Arch Mikrobiol (1967) 1.21
Myxothiazol, a new inhibitor of the cytochrome b-c1 segment of th respiratory chain. Biochim Biophys Acta (1981) 1.21
Two binding sites of inhibitors in NADH: ubiquinone oxidoreductase (complex I). Relationship of one site with the ubiquinone-binding site of bacterial glucose:ubiquinone oxidoreductase. Eur J Biochem (1994) 1.21
The corallopyronins, new inhibitors of bacterial RNA synthesis from Myxobacteria. J Antibiot (Tokyo) (1985) 1.20
Elevated blood pressure and enhanced myocardial contractility in mice with severe IGF-1 deficiency. J Clin Invest (1996) 1.20
Effects of arousing emotional scenes on the distribution of visuospatial attention: changes with aging and early subcortical vascular dementia. J Neurol Sci (2004) 1.19
Plaque ulceration and lumen thrombus are the main sources of cerebral microemboli in high-grade internal carotid artery stenosis. Stroke (1995) 1.18
The correlation between morphological and phylogenetic classification of myxobacteria. Int J Syst Bacteriol (1999) 1.15
Chondramides A approximately D, new antifungal and cytostatic depsipeptides from Chondromyces crocatus (myxobacteria). Production, physico-chemical and biological properties. J Antibiot (Tokyo) (1995) 1.13
Identification of the yeast ACC1 gene product (acetyl-CoA carboxylase) as the target of the polyketide fungicide soraphen A. Curr Genet (1994) 1.12
The ripostatins, novel inhibitors of eubacterial RNA polymerase isolated from myxobacteria. J Antibiot (Tokyo) (1995) 1.12
Cerebral vasomotor changes in the transient syndrome of headache with neurologic deficits and CSF lymphocytosis (HaNDL). Headache (1997) 1.12
Magnetic stimuli applied over motor and visual cortex: influence of coil position and field polarity on motor responses, phosphenes, and eye movements. Electroencephalogr Clin Neurophysiol Suppl (1991) 1.11
Hand skill asymmetry in professional musicians. Brain Cogn (1997) 1.09
The myxochelin iron transport regulon of the myxobacterium Stigmatella aurantiaca Sg a15. Eur J Biochem (2000) 1.09
Carotenoid pigments of Stigmatella aurantiaca (Myxobacterales). II. Acylated carotenoid glucosides. Arch Mikrobiol (1970) 1.09
Restriction endonucleases: general survey procedure and survey of gliding bacteria. J Bacteriol (1978) 1.08
On the mechanism of action of the myxobacterial fungicide ambruticin. J Antibiot (Tokyo) (2000) 1.08
Time trends in systemic thrombolysis in a large hospital-based stroke registry. Cerebrovasc Dis (2012) 1.08
Unsolved problems in comparing brain sizes in Homo sapiens. Brain Cogn (1998) 1.07
Inflammation in high-grade carotid stenosis: a possible role for macrophages and T cells in plaque destabilization. Stroke (1998) 1.07
Reversible intracranial circulatory arrest in acute subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (1988) 1.07
Association of the Adh Locus with a lethal factor (1(2)stm) in Drosophila melanogaster. Biochem Genet (1976) 1.06
Epothilone B stabilizes microtubuli of macrophages like taxol without showing taxol-like endotoxin activity. Cancer Res (1997) 1.06
Nannocystis exedens gen. nov., spec. nov., a new myxobacterium of the family Sorangiaceae. Arch Mikrobiol (1970) 1.06
Myxothiazol, an antibiotic from Myxococcus fulvus (myxobacterales). I. Cultivation, isolation, physico-chemical and biological properties. J Antibiot (Tokyo) (1980) 1.06
Tubulysins, new cytostatic peptides from myxobacteria acting on microtubuli. Production, isolation, physico-chemical and biological properties. J Antibiot (Tokyo) (2000) 1.06
Slowing fastest finger movements of the dominant hand with low-frequency rTMS of the hand area of the primary motor cortex. Exp Brain Res (2003) 1.04
Differential magnetic resonance signal change in human sensorimotor cortex to finger movements of different rate of the dominant and subdominant hand. Brain Res Cogn Brain Res (1998) 1.03
Myxothiazol, an antibiotic from Myxococcus fulvus (myxobacterales). II. structure elucidation. J Antibiot (Tokyo) (1980) 1.02
fMRI study of bimanual coordination. Neuropsychologia (2000) 1.02
Pravastatin improves cerebral vasomotor reactivity in patients with subcortical small-vessel disease. Stroke (2001) 1.02
Mucopolysaccharidoses and anaesthetic risks. Acta Anaesthesiol Scand (1987) 1.02
Cheyne-Stokes respiration in ischemic stroke. Neurology (1995) 1.02
Crocacin, a new electron transport inhibitor from Chondromyces crocatus (myxobacteria). Production, isolation, physico-chemical and biological properties. J Antibiot (Tokyo) (1994) 1.01
Biologically active secondary metabolites from myxobacteria. Biotechnol Adv (1993) 1.01
Bilateral reductions of hippocampal volume, glucose metabolism, and wada hemispheric memory performance are related to the duration of mesial temporal lobe epilepsy. J Neurol (1999) 1.01
Involvement of the central nervous system and its coverings in different forms of amyloidosis. Prog Clin Biol Res (1989) 1.00
Apicularens A and B, new cytostatic macrolides from Chondromyces species (myxobacteria): production, physico-chemical and biological properties. J Antibiot (Tokyo) (1998) 0.99
Carotenoid glucosides and menaquinones from the gliding bacterium Herpetosiphon giganteus Hp a2. Arch Microbiol (1977) 0.99
The soraphens: a family of novel antifungal compounds from Sorangium cellulosum (Myxobacteria). I. Soraphen A1 alpha: fermentation, isolation, biological properties. J Antibiot (Tokyo) (1994) 0.99
Carotenoid pigments of Stigmatella aurantiaca (Myxobacterales).I. The minor carotenoids. Arch Mikrobiol (1969) 0.98
The myxovirescins, a family of antibiotics from Myxococcus virescens (Myxobacterales). J Antibiot (Tokyo) (1982) 0.97
Child age and planum temporale asymmetry. Brain Cogn (1999) 0.97
The jerangolids: A family of new antifungal compounds from Sorangium cellulosum (Myxobacteria). Production, physico-chemical and biological properties of jerangolid A. J Antibiot (Tokyo) (1996) 0.94